The British Society for Allergy and Clinical Immunology (BSACI) does not recommend EURneffy as the sole rescue therapy for people who have previously required more than one dose of adrenaline to treat anaphylaxis, or who have experienced severe anaphylaxis with hypotension (which is more common in individuals with an allergy to insect venom). BSACI advises that these patients should continue to have access to adrenaline autoinjectors. Further information is available in the BSACI EURneffy Statement.